Compounds and Compositions for Treating Fibrosis
AssigneeYale University
InventorsAnton Bennett, Jonathan Ellman, Haya Jamali, Karen S. Anderson, Elias Lolis, Denton Hoyer
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds and methods for treating, ameliorating, and/or preventing a MKP-5 modulated disease. In certain embodiments, the MKP-5 modulated disease is a fibrotic disease.
Claims19
A method of treating, ameliorating, or preventing a MKP-5-modulated disease or disorder in a mammal, the method comprising administering to the mammal a therapeutically effective amount of a compound of formula (1a) or (1b), or a pharmaceutically acceptable salt or solvate thereof:
- wherein:
- Z is selected from the group consisting of NR, NC(═O)R, CH2 and O and the bond is single;
- or
- Z is N and the bond is double;
- R1 is selected from the group consisting of C1-C6 alkyl, optionally substituted phenyl and NRR;
- each occurrence of R is independently selected from the group consisting of H, C1-C6 alkyl and optionally substituted phenyl;
- A is selected from the group consisting of optionally substituted phenyl and optionally substituted heteroaryl.
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt or solvate thereof.
A kit for preventing, ameliorating, or treating a MKP-5 modulated disease or disorder in a mammal, the kit comprising a MKP-5 inhibitor, optionally an applicator, and an instructional material for use thereof, wherein the instructional material recites the amount of, and frequency with which, the MKP-5 inhibitor is to be administered to the mammal to treat or prevent the MKP-5 modulated disease or disorder.
A method of determining if a test compound is a MKP-5 inhibitor, the method comprising:
- contacting a test compound with (i) a substrate peptide comprising the amino acid sequence pThr-Gly-pTyr and (ii) a catalytic polypeptide comprising and/or consisting of the catalytic domain of MKP-5, or an active fragment thereof, thus forming a composition;
- measuring MKP-5 activity in the composition;
- and
- comparing the MKP-5 activity in the composition to a control;
- thereby determining if the test compound is a MKP-5 inhibitor.
Dependencies are inferred from the claim text.